U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT06985628) titled 'Alleviating Dyspnea With Non-Invasive Neuromodulation' on Aug. 15, 2024.
Brief Summary: The goal of this feasibility sham-controlled randomized trial is to assess the feasibility of studying non-invasive neuromodulation techniques, specifically transcutaneous vagal nerve stimulation (tVNS) and transcutaneous electrical nerve stimulation (TENS) of the trigeminal nerve to alleviate dyspnea in patients with chronic pulmonary disease.
The main question it aims to answer is:
Despite challenges in dyspnea generation and measurement, could non-invasive neuromodulation be reliably studied in chronic obstructive pulmonary disease (COPD) wit...